[Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma]

Area of Science:

• Epigenetics and molecular biology
• Cancer genomics and transcriptomics

Context:

• Aberrant epigenetic modifications and coding gene mutations are increasingly recognized in cancer development.
• Epigenetics encompasses DNA methylation, histone modifications, and microRNA (miRNA) regulation.
• miRNAs are non-coding RNAs that regulate gene expression post-transcriptionally.

Purpose:

• To investigate the role of microRNAs (miRNAs) and other epigenetic mechanisms in the progression of multiple myeloma (MM).
• To explore the relationship between miRNA expression and their target genes in MM.
• To assess the potential of miRNA as biomarkers for predicting patient outcomes and developing novel therapies.

Summary:

• In multiple myeloma (MM), a significant decrease in the expression of several miRNAs was observed.
• Concurrently, target genes regulated by these miRNAs, particularly those involved in apoptosis and cell cycle control, showed increased expression.
• Negative correlations between miRNA and target gene expression levels were identified, suggesting a regulatory imbalance.
• The miR-34 family was found to be epigenetically silenced through methylation, further highlighting miRNA dysregulation in MM.
• These epigenetic alterations, including miRNA dysregulation, are hypothesized to contribute to MM network formation and disease progression.

Impact:

• Understanding miRNA dysregulation in MM provides critical insights into disease pathogenesis.
• Identifying specific miRNA-target gene interactions can lead to the development of novel therapeutic strategies for multiple myeloma.
• miRNA profiling may serve as a valuable tool for predicting patient prognosis and guiding treatment decisions.